CN101816742A - Chinese medicinal composition for treating hemorrhoids and preparation method thereof - Google Patents
Chinese medicinal composition for treating hemorrhoids and preparation method thereof Download PDFInfo
- Publication number
- CN101816742A CN101816742A CN201010189679A CN201010189679A CN101816742A CN 101816742 A CN101816742 A CN 101816742A CN 201010189679 A CN201010189679 A CN 201010189679A CN 201010189679 A CN201010189679 A CN 201010189679A CN 101816742 A CN101816742 A CN 101816742A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- herba
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixtures Substances 0.000 title claims abstract description 52
- 208000002287 Hemorrhoids Diseases 0.000 title claims abstract description 47
- 238000002360 preparation methods Methods 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 56
- 210000003491 Skin Anatomy 0.000 claims abstract description 12
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 10
- 229940097275 Indigo Drugs 0.000 claims abstract description 10
- 240000007871 Indigofera tinctoria Species 0.000 claims abstract description 10
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims abstract description 10
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 8
- 241000207929 Scutellaria Species 0.000 claims abstract description 8
- 239000002775 capsule Substances 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims description 27
- 210000000582 Semen Anatomy 0.000 claims description 13
- 244000235603 Acacia catechu Species 0.000 claims description 9
- 241001489978 Eupolyphaga Species 0.000 claims description 9
- 239000004863 Frankincense Substances 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 241000283956 Manis Species 0.000 claims description 9
- 241001057584 Myrrha Species 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 208000009189 Tinea Favosa Diseases 0.000 claims description 9
- 206010043866 Tinea capitis Diseases 0.000 claims description 9
- 239000008517 radix Trichosanthis Substances 0.000 claims description 9
- 235000005903 Dioscorea Nutrition 0.000 claims description 7
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 7
- 244000111489 Gardenia augusta Species 0.000 claims description 7
- 241000245240 Lonicera Species 0.000 claims description 7
- 229940023488 Pill Drugs 0.000 claims description 7
- 241001530126 Scrophularia Species 0.000 claims description 7
- 241000405217 Viola <butterfly> Species 0.000 claims description 7
- 235000004879 dioscorea Nutrition 0.000 claims description 7
- 239000008187 granular materials Substances 0.000 claims description 7
- 239000006187 pills Substances 0.000 claims description 7
- 239000000843 powders Substances 0.000 claims description 7
- 229940079593 drugs Drugs 0.000 claims description 5
- 239000007788 liquids Substances 0.000 claims description 5
- 241001116389 Aloe Species 0.000 claims description 4
- 241000756943 Codonopsis Species 0.000 claims description 4
- 241000660877 Coridius Species 0.000 claims description 4
- 235000011399 aloe vera Nutrition 0.000 claims description 4
- 229910052602 gypsum Inorganic materials 0.000 claims description 4
- 239000010440 gypsum Substances 0.000 claims description 4
- 239000009286 sanguis draxonis Substances 0.000 claims description 4
- 239000003826 tablets Substances 0.000 claims description 3
- 241000605447 Anemarrhena Species 0.000 claims description 2
- 239000008589 Cortex Fraxini Substances 0.000 claims description 2
- 240000008219 Euryale ferox Species 0.000 claims description 2
- 235000006487 Euryale ferox Nutrition 0.000 claims description 2
- 244000241601 filaree Species 0.000 claims 2
- 239000011901 water Substances 0.000 claims 2
- 240000005760 Dioscorea villosa Species 0.000 claims 1
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 240000006089 Sanguisorba officinalis Species 0.000 claims 1
- 240000006694 Stellaria media Species 0.000 claims 1
- 210000000436 anus Anatomy 0.000 abstract description 22
- 239000002994 raw material Substances 0.000 abstract description 10
- 206010018836 Haematochezia Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 230000028327 secretion Effects 0.000 abstract description 4
- 201000009910 diseases by infectious agent Diseases 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 2
- 235000003417 Plumeria rubra f acutifolia Nutrition 0.000 abstract 2
- 244000040691 Plumeria rubra f. acutifolia Species 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000271309 Aquilaria crassna Species 0.000 abstract 1
- 240000005368 Areca catechu Species 0.000 abstract 1
- 241000130781 Arnebia Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 206010011469 Crying Diseases 0.000 abstract 1
- 241000099774 Cuscuta salina Species 0.000 abstract 1
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 241000533849 Gleditsia Species 0.000 abstract 1
- 235000008694 Humulus lupulus Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 240000003146 Lobelia chinensis Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 240000008259 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 240000000805 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 240000002924 Platycladus orientalis Species 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 240000008251 Pterocarpus indicus Species 0.000 abstract 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 241000130764 Tinea Species 0.000 abstract 1
- 208000002474 Tinea Diseases 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000009242 dandelion Nutrition 0.000 abstract 1
- 235000014079 dandelion Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052683 pyrite Inorganic materials 0.000 abstract 1
- 239000011028 pyrite Substances 0.000 abstract 1
- 210000000456 talus bone Anatomy 0.000 abstract 1
- 239000002023 wood Substances 0.000 abstract 1
- 210000004369 Blood Anatomy 0.000 description 25
- 239000008280 blood Substances 0.000 description 25
- 206010018987 Haemorrhage Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,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 data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nODVweCcgaGVpZ2h0PSc4NXB4JyB2aWV3Qm94PScwIDAgODUgODUnPgo8IS0tIEVORCBPRiBIRUFERVIgLS0+CjxyZWN0IHN0eWxlPSdvcGFjaXR5OjEuMDtmaWxsOiNGRkZGRkY7c3Ryb2tlOm5vbmUnIHdpZHRoPSc4NScgaGVpZ2h0PSc4NScgeD0nMCcgeT0nMCc+IDwvcmVjdD4KPHRleHQgeD0nMTMuMzEyOCcgeT0nNTMuNTkwOScgY2xhc3M9J2F0b20tMCcgc3R5bGU9J2ZvbnQtc2l6ZToyM3B4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6I0U4NDIzNScgPkg8L3RleHQ+Cjx0ZXh0IHg9JzI4LjE1NjknIHk9JzYyLjg2MzYnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6MTVweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID4yPC90ZXh0Pgo8dGV4dCB4PSczNS4wNDU1JyB5PSc1My41OTA5JyBjbGFzcz0nYXRvbS0wJyBzdHlsZT0nZm9udC1zaXplOjIzcHg7Zm9udC1zdHlsZTpub3JtYWw7Zm9udC13ZWlnaHQ6bm9ybWFsO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTpub25lO2ZvbnQtZmFtaWx5OnNhbnMtc2VyaWY7dGV4dC1hbmNob3I6c3RhcnQ7ZmlsbDojRTg0MjM1JyA+TzwvdGV4dD4KPC9zdmc+Cg== O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 230000003203 everyday Effects 0.000 description 9
- 201000007772 internal hemorrhoid Diseases 0.000 description 8
- 241000717739 Boswellia sacra Species 0.000 description 7
- 230000000740 bleeding Effects 0.000 description 7
- 231100000319 bleeding Toxicity 0.000 description 7
- 230000002522 swelling Effects 0.000 description 7
- 241000234273 Dioscorea Species 0.000 description 6
- 241000555712 Forsythia Species 0.000 description 6
- 241000581682 Sanguisorba Species 0.000 description 6
- 241000722081 Stellaria <angiosperm> Species 0.000 description 6
- 210000003462 Veins Anatomy 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 210000000056 organs Anatomy 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 208000007502 Anemia Diseases 0.000 description 4
- 206010025482 Malaise Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 241000668709 Dipterocarpus costatus Species 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 230000001225 therapeutic Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000002173 Dizziness Diseases 0.000 description 2
- 208000007906 Intestinal Disease Diseases 0.000 description 2
- 206010022972 Iron deficiency anaemia Diseases 0.000 description 2
- 206010036772 Proctalgia Diseases 0.000 description 2
- 210000002700 Urine Anatomy 0.000 description 2
- 206010048245 Yellow skin Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000000240 adjuvant Effects 0.000 description 2
- 201000010188 anus disease Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 231100000486 side effect Toxicity 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- 210000001015 Abdomen Anatomy 0.000 description 1
- 206010002644 Anorectal disease Diseases 0.000 description 1
- 210000001367 Arteries Anatomy 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010061428 Decreased appetite Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 210000003608 Feces Anatomy 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products data:image/svg+xml;base64,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 data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nODVweCcgaGVpZ2h0PSc4NXB4JyB2aWV3Qm94PScwIDAgODUgODUnPgo8IS0tIEVORCBPRiBIRUFERVIgLS0+CjxyZWN0IHN0eWxlPSdvcGFjaXR5OjEuMDtmaWxsOiNGRkZGRkY7c3Ryb2tlOm5vbmUnIHdpZHRoPSc4NScgaGVpZ2h0PSc4NScgeD0nMCcgeT0nMCc+IDwvcmVjdD4KPHBhdGggY2xhc3M9J2JvbmQtMCcgZD0nTSAxOC4xMzE4LDQ4LjQ4MyBMIDI2LjA4OTIsNTMuMDc3Micgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzQyODRGNDtzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMCcgZD0nTSAyNi4wODkyLDUzLjA3NzIgTCAzNC4wNDY2LDU3LjY3MTQnIHN0eWxlPSdmaWxsOm5vbmU7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiMzQjQxNDM7c3Ryb2tlLXdpZHRoOjEuMHB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEnIC8+CjxwYXRoIGNsYXNzPSdib25kLTEnIGQ9J00gMzQuMDQ2Niw1Ny42NzE0IEwgNTMuMTYxOCw0Ni42MzUyJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0yJyBkPSdNIDUzLjE2MTgsNDYuNjM1MiBMIDYxLjExOTEsNTEuMjI5NCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMicgZD0nTSA2MS4xMTkxLDUxLjIyOTQgTCA2OS4wNzY1LDU1LjgyMzYnIHN0eWxlPSdmaWxsOm5vbmU7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiNFODQyMzU7c3Ryb2tlLXdpZHRoOjEuMHB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEnIC8+CjxwYXRoIGNsYXNzPSdib25kLTMnIGQ9J00gNTUuMzY5LDQ2LjYzNTIgTCA1NS4zNjksMzguMDgyMicgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMycgZD0nTSA1NS4zNjksMzguMDgyMiBMIDU1LjM2OSwyOS41MjkxJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojRTg0MjM1O3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0zJyBkPSdNIDUwLjk1NDUsNDYuNjM1MiBMIDUwLjk1NDUsMzguMDgyMicgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMycgZD0nTSA1MC45NTQ1LDM4LjA4MjIgTCA1MC45NTQ1LDI5LjUyOTEnIHN0eWxlPSdmaWxsOm5vbmU7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiNFODQyMzU7c3Ryb2tlLXdpZHRoOjEuMHB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEnIC8+Cjx0ZXh0IHg9JzMuMzYzNjQnIHk9JzUxLjA0OTcnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6OHB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6IzQyODRGNCcgPkg8L3RleHQ+Cjx0ZXh0IHg9JzkuNDU1NjEnIHk9JzU0LjU4MTInIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6NXB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6IzQyODRGNCcgPjI8L3RleHQ+Cjx0ZXh0IHg9JzEyLjI4MjYnIHk9JzUxLjA0OTcnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6OHB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6IzQyODRGNCcgPk48L3RleHQ+Cjx0ZXh0IHg9JzY5LjYyODMnIHk9JzYyLjA4NTknIGNsYXNzPSdhdG9tLTMnIHN0eWxlPSdmb250LXNpemU6OHB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6I0U4NDIzNScgPk88L3RleHQ+Cjx0ZXh0IHg9Jzc1LjcyMDMnIHk9JzYyLjA4NTknIGNsYXNzPSdhdG9tLTMnIHN0eWxlPSdmb250LXNpemU6OHB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6I0U4NDIzNScgPkg8L3RleHQ+Cjx0ZXh0IHg9JzUwLjUxMzEnIHk9JzI4Ljk3NzMnIGNsYXNzPSdhdG9tLTQnIHN0eWxlPSdmb250LXNpemU6OHB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6I0U4NDIzNScgPk88L3RleHQ+Cjwvc3ZnPgo= NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020651 Hyperkinesia Diseases 0.000 description 1
- 208000000269 Hyperkinesis Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 240000008962 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 210000000664 Rectum Anatomy 0.000 description 1
- 101700050571 SUOX Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000008203 Tachypnea Diseases 0.000 description 1
- 206010043089 Tachypnoea Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 210000002255 anal canal Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 230000002996 emotional Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 230000002650 habitual Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 230000036544 posture Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Abstract
The invention discloses a Chinese medicinal composition for treating hemorrhoids and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: hops, pagodatree pod, pagodatree flower bud, Indian buead, lightyellow sophora root, figwort root, swordlike atractylodes rhizome, large-headed atractylodes rhizome, cinnamomvine, ground beeltle, szechwan chinaberry fruit, catechu, pyrite, Jiuxiang bug, szechuan lovage rhizome, Chinese eaglewood, rosewood heart wood, charred Chinese arborvitae twig, garden burnet root, gleditsia thorn, pangolin scales, double blossom, violet, sinkiang arnebia root, mongolian dandelion herb, weeping forsythiae capsule, raw astragalus, Chinese angelica, root of red-rooted salvia, pilose asiabell root, tree peony bark, gardenia, mongolian snakegourd root, baical skullcap root, golden thread, tinea alba skin, ash bark, red paeony root, pariphyllin, natural indigo, dahurian patrinia herb, Chinese lobelia herb and the like. The Chinese medicinal composition can be prepared into any one common orally-taken preparation by a conventional Chinese medicinal preparation method. The Chinese medicinal composition can remarkably improve the symptoms: blood stool, pain and prolapse of hemorrhoids, increased secretion caused thereby, discomfort with wet and damp anus, infection, tumefaction, pain and other symptoms, and has the advantages of extract clinical treatment effect, remarkable treatment effect and quick response.
Description
?
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of hemorrhoid.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment hemorrhoid of crude drug with the Chinese herbal medicine.
Background technology
Human body rectum end mucosa down and under the anal canal skin venous plexus take place to expand and the formed soft vein of flexing group, be called hemorrhoid, have another name called hemorrhoid, blood stasis, hemorrhoid disease, haemorrhoids etc.Medical science indication hemorrhoid comprise internal hemorrhoid, external hemorrhoid, mixed hemorrhoid.Show that according to relevant reconnaissance information the sickness rate of anorectal disease is 59.1%, hemorrhoid account for 87.25% of all anal and intestinal diseases, and wherein common with internal hemorrhoid, account for 52.19% of all anal and intestinal diseases.The men and women all can fall ill, and women's sickness rate is 67%, and male's sickness rate is 53.9%; Any age all can fall ill, and wherein the people in 20-40 year comparatively more sees, and increases the weight of with advancing age and gradually.
The hemorrhoid pathogenic factor is a lot of, sitting, station, fatigue etc. for a long time make human body be in a kind of fixation postures for a long time, thereby influence blood circulation, make slow blood flow and the interior internal organs hyperemia of abdomen in the pelvic cavity, cause that haemorrhoidal vein over filling, varicose, protuberance, wall of vein tension force descend and causes that hemorrhoid are one of major reasons of morbidity.If hypomotility, enterokinesia is slowed down, and feces is descending slow or because of habitual constipation, thereby the compressing vein makes contrafluxion and blood backflow obstacle, causes the intrinsic pressure rising of haemorrhoidal vein, and the wall of vein resistance reduces, and also can cause the hemorrhoid sickness rate to increase.The topmost symptom of hemorrhoid is to have blood in stool and deviate from, and repeated multiple times ground is hemorrhage during stool, makes and loses a large amount of ferrum in the body, causes iron deficiency anemia, and how with pain, has a strong impact on Health and Living.
The hemorrhoid symptom is divided into four grades: first is in anal swelling; Second hemorrhoid when spending can be deviate from defecation, but the i.e. withdrawal anal automatically in the intact back of defecation.During to the third level, then can't withdraw automatically, must hemorrhoid be pushed back anal with hands.Just deviate from when the most serious outside the anus and can't push back.
It is hemorrhage at first to defecate, and outbreak feels to have thing to deviate from outside the anus constantly, or anus swells and ache outward, and secretions increases, and often pollutes underwear, promptly roughly thinks and has suffered from hemorrhoid.Secondly, hemorrhage when the main performance of internal hemorrhoid phase is stool, and blood volume is more, drop and descending sometimes, and often have spurting to have blood in stool, no pain and other discomforts, hemorrhage with the passing of time, amount is many can cause anemia, very then visible Light-headedness, the fatigue and weak of breathing hard, listless; And internal hemorrhoid has blood stasis to deviate from outside the anus to mid-term in the time of just, and blood stasis can also be received in the anus voluntarily after an action of the bowels; Stage (being internal hemorrhoid late period), blood stasis is deviate from outside the anus greatly after an action of the bowels, can not also receive anal voluntarily, need to borrow the external force of hands, or after having a rest, could also receive anus, cough, work, effort, work or overfatigue, all can deviate from outside the anus, and secretions increase, the wet tide of anus does not relax.If hyperkinesia, it is heavier rub, can infection, swelling, pain, if can not in time also receive anus at this moment, blood stasis incarceration, necrosis can appear, and medically, be called incarcerated hemorrhoid these type of hemorrhoid.But the middle and advanced stage internal hemorrhoid is generally because of hemorrhoid surface fiber hamartoplasia, most hemorrhage minimizings, and with deviate from, secretions increases to the master.The harm of hemorrhoid: the iron deficiency anemia that hemorrhoid cause because of losing blood, general slower development, can there be symptom or symptom slight in early days, anemia is heavier or when making fast progress, can occur then that pale complexion, fatigue and weakness, inappetence, cardiopalmus, heart rate are accelerated and physical exertion after tachypnea, edema etc., neurological symptom such as emotional, excited, agitation etc. can appear in some patients, and the someone thinks in the cell due to the iron content azymia.More than these symptoms all can after correcting anemia, treatment hemorrhoid, disappear.Therefore if find to suffer from hemorrhoid, should treat as early as possible,, make treatment complicated in order to avoid above-mentioned symptom occurs.Another cardinal symptom of hemorrhoid is that internal hemorrhoid is deviate from.Emerge in the outer internal hemorrhoid of anus, be subjected to sphincteral clamping, venous return is obstructed, and arterial blood still constantly input the blood stasis volume is increased, pressed off until arteries, blood stasis hardening, pain appear in thrombosis, are difficult to send back to anal.Traditional view claims " strangulated internal hemorrhoids ".But the clinical findings external hemorrhoid is thrombosedly seen more, thus many with pain, when blood stasis is deviate to send back to, also be called " incarcerated hemorrhoid ".
Modern medicine is at clinical a certain symptom treatment, often fall flat, can not find suitable Therapeutic Method, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment hemorrhoid, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical accent, emergency is taken in concurrently, filter out the natural plant of benefiting qi and nourishing yin, hemostasis by removing blood stasis, heat-clearing and toxic substances removing,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment hemorrhoid that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
?
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment hemorrhoid of evident in efficacy, with low cost, almost non-toxic side effect is provided.
The technical problem of the desired solution of the present invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of hemorrhoid of the present invention, the component of main following weight portion is formed:
1～100 part in Flos Sophorae, 1～150 part of the Fructus Sophorae, 1～100 part of the Flos Sophorae Immaturus, 1～150 part in Poria, 1～120 part of Radix Sophorae Flavescentis, 1～120 part of Radix Scrophulariae, 1～100 part of Rhizoma Atractylodis, 1～120 part of the Rhizoma Atractylodis Macrocephalae, 1～120 part of Rhizoma Dioscoreae, 1～100 part of Eupolyphaga Seu Steleophaga, 1～120 part of Fructus Toosendan, 1～50 part in catechu, 1～50 part of Pyritum, 1～100 part of Platycladi Cacumen carbonisatum, 1～120 part of Radix Sanguisorbae, 1～50 part of Spina Gleditsiae, 1～50 part of Squama Manis, 1～120 part of Flos Lonicerae, 1～100 part of Herba Violae, 1～120 part of Radix Arnebiae (Radix Lithospermi), 1～50 part of Herba Lobeliae Chinensis, 1～100 part of Herba Hedyotidis Diffusae, 1～100 part of water clock, 1～100 part of Rhizoma Smilacis Glabrae, 1～120 part of Cortex Lycii, 1～100 part of Radix Stellariae, 1～100 part of Rhizoma Picrorhizae, 1～120 part of Herba Taraxaci, 1～50 part of Fructus Forsythiae, 1～120 part of Radix Astragali, 1～120 part of the Radix Paeoniae Alba, 1～120 part of Radix Angelicae Sinensis, 1～50 part of Olibanum (processed), 1～50 part of Myrrha (processed), 1～150 part of Radix Trichosanthis, 1～50 part of Fructus Gardeniae, 1～120 part of Radix Scutellariae, 1～100 part of Rhizoma Coptidis, 1～120 part of favus skin.
Be preferably:
30 parts in Flos Sophorae, 50 parts of the Fructuss Sophorae, 30 parts of the Flos Sophorae Immaturus, 50 parts in Poria, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Radix Scrophulariaes, 20 parts of Rhizoma Atractylodis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Rhizoma Dioscoreaes, 15 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Toosendans, 15 parts in catechu, 15 parts of Pyritums, 30 parts of Platycladi Cacumen carbonisatum, 30 parts of Radix Sanguisorbaes, 15 parts of Spina Gleditsiae, 15 parts of Squama Maniss, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes, 20 parts of water clocks, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 30 parts of Radix Astragali, 20 parts of the Radix Paeoniae Albas, 30 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Trichosanthis, 15 parts of Fructus Gardeniaes, 20 parts of Radix Scutellariaes, 15 parts of Rhizoma Coptidis, 30 parts of favus skins.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1～120 part of Cortex Fraxini, 1～100 part of Radix Rehmanniae, 1～100 part of Radix Paeoniae Rubra, 1～50 part of Rhizoma Paridis, 1～50 part of Indigo Naturalis, 1～100 part of Herba Patriniae, 1～50 part of Aspongopus, 1～100 part of Rhizoma Chuanxiong, 1～50 part of Lignum Aquilariae Resinatum, 1～100 part of Lignum Dalbergiae Odoriferae, 1～100 part of Aloe, 1～100 part of Radix Salviae Miltiorrhizae, 1～100 part of Radix Codonopsis, 1～120 part of Cortex Moutan, 1～100 part of Semen Pruni, 1～100 part of Radix Et Rhizoma Rhei, 1～100 part of Lignum Sappan, 1～30 part of Sanguis Draxonis, 1～100 part of Semen Euryales, 1～50 part in Semen Nelumbinis, 1～50 part of Halloysitum Rubrum, 1～100 part of Gypsum Fibrosum, 1～50 part of the Rhizoma Anemarrhenae, 1～50 part of Limonitum, 1～50 part of Pericarpium Granati.
Be preferably:
30 parts of Cortex Fraxinis, 20 parts of Radix Rehmanniae, 20 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Paridis, 15 parts of Indigo Naturaliss, 30 parts of Herba Patriniae, 15 parts of Aspongopuss, 15 parts of Rhizoma Chuanxiongs, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Aloes, 20 parts of Radix Salviae Miltiorrhizaes, 30 parts of Radix Codonopsis, 20 parts of Cortex Moutans, 20 parts of Semen Prunis, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Lignum Sappans, 10 parts of Sanguis Draxonis, 20 parts of Semen Euryaless, 15 parts in Semen Nelumbinis, 15 parts of Halloysitum Rubrums, 20 parts of Gypsum Fibrosum, 15 parts of the Rhizoma Anemarrhenaes, 25 parts of Limonitum, 25 parts of Pericarpium Granatis.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The treatment that the present invention is directed to hemorrhoid patients is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 30 parts in Flos Sophorae, 50 parts of the Fructuss Sophorae, 30 parts of the Flos Sophorae Immaturus, 50 parts in Poria, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Radix Scrophulariaes, 20 parts of Rhizoma Atractylodis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Rhizoma Dioscoreaes, 15 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Toosendans, 15 parts in catechu, 15 parts of Pyritums, 30 parts of Platycladi Cacumen carbonisatum, 30 parts of Radix Sanguisorbaes, 15 parts of Spina Gleditsiae, 15 parts of Squama Maniss, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes, 20 parts of water clocks, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 30 parts of Radix Astragali, 20 parts of the Radix Paeoniae Albas, 30 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Trichosanthis, 15 parts of Fructus Gardeniaes, 20 parts of Radix Scutellariaes, 15 parts of Rhizoma Coptidis, 30 parts of favus skins, 15 parts of Indigo Naturaliss, 30 parts of Herba Patriniae, 25 parts of Limonitum, 25 parts of Pericarpium Granatis.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 30 parts in Flos Sophorae, 50 parts of the Fructuss Sophorae, 30 parts of the Flos Sophorae Immaturus, 50 parts in Poria, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Radix Scrophulariaes, 20 parts of Rhizoma Atractylodis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Rhizoma Dioscoreaes, 15 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Toosendans, 15 parts in catechu, 15 parts of Pyritums, 30 parts of Platycladi Cacumen carbonisatum, 30 parts of Radix Sanguisorbaes, 15 parts of Spina Gleditsiae, 15 parts of Squama Maniss, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes, 20 parts of water clocks, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 30 parts of Radix Astragali, 20 parts of the Radix Paeoniae Albas, 30 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Trichosanthis, 15 parts of Fructus Gardeniaes, 20 parts of Radix Scutellariaes, 15 parts of Rhizoma Coptidis, 30 parts of favus skins, 15 parts of Indigo Naturaliss, 30 parts of Herba Patriniae, 25 parts of Limonitum, 25 parts of Pericarpium Granatis.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material by following weight portion: 30 parts in Flos Sophorae, 50 parts of the Fructuss Sophorae, 30 parts of the Flos Sophorae Immaturus, 50 parts in Poria, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Radix Scrophulariaes, 20 parts of Rhizoma Atractylodis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Rhizoma Dioscoreaes, 15 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Toosendans, 15 parts in catechu, 15 parts of Pyritums, 30 parts of Platycladi Cacumen carbonisatum, 30 parts of Radix Sanguisorbaes, 15 parts of Spina Gleditsiae, 15 parts of Squama Maniss, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes, 20 parts of water clocks, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 30 parts of Radix Astragali, 20 parts of the Radix Paeoniae Albas, 30 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Trichosanthis, 15 parts of Fructus Gardeniaes, 20 parts of Radix Scutellariaes, 15 parts of Rhizoma Coptidis, 30 parts of favus skins, 15 parts of Indigo Naturaliss, 30 parts of Herba Patriniae, 25 parts of Limonitum, 25 parts of Pericarpium Granatis.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material by following weight portion: 30 parts in Flos Sophorae, 50 parts of the Fructuss Sophorae, 30 parts of the Flos Sophorae Immaturus, 50 parts in Poria, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Radix Scrophulariaes, 20 parts of Rhizoma Atractylodis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Rhizoma Dioscoreaes, 15 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Toosendans, 15 parts in catechu, 15 parts of Pyritums, 30 parts of Platycladi Cacumen carbonisatum, 30 parts of Radix Sanguisorbaes, 15 parts of Spina Gleditsiae, 15 parts of Squama Maniss, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes, 20 parts of water clocks, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 30 parts of Radix Astragali, 20 parts of the Radix Paeoniae Albas, 30 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Trichosanthis, 15 parts of Fructus Gardeniaes, 20 parts of Radix Scutellariaes, 15 parts of Rhizoma Coptidis, 30 parts of favus skins, 15 parts of Indigo Naturaliss, 30 parts of Herba Patriniae, 25 parts of Limonitum, 25 parts of Pericarpium Granatis.
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material by following weight portion: 30 parts in Flos Sophorae, 50 parts of the Fructuss Sophorae, 30 parts of the Flos Sophorae Immaturus, 50 parts in Poria, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Radix Scrophulariaes, 20 parts of Rhizoma Atractylodis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Rhizoma Dioscoreaes, 15 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Toosendans, 15 parts in catechu, 15 parts of Pyritums, 30 parts of Platycladi Cacumen carbonisatum, 30 parts of Radix Sanguisorbaes, 15 parts of Spina Gleditsiae, 15 parts of Squama Maniss, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes, 20 parts of water clocks, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 30 parts of Radix Astragali, 20 parts of the Radix Paeoniae Albas, 30 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Trichosanthis, 15 parts of Fructus Gardeniaes, 20 parts of Radix Scutellariaes, 15 parts of Rhizoma Coptidis, 30 parts of favus skins, 15 parts of Indigo Naturaliss, 30 parts of Herba Patriniae, 25 parts of Limonitum, 25 parts of Pericarpium Granatis.
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into
Normal concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
The clinical observation on the therapeutic effect experiment of [experimental example] traditional Chinese medicine composition for treating hemorrhoid patients of the present invention
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 75 routine patients altogether, wherein male 59 examples, women 16 examples; The oldest person 71 years old, the age reckling has only 13 years old.
Two, Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 2 courses of treatment altogether.
Three, therapeutic evaluation standard
Cure: sign and symptom are improved fully, and be happy, in high spirits.
Produce effects: sign and symptom are significantly improved, and be happy, and spirit is fine.
Effectively: sign and symptom change, and random thoughts have discomfort slightly, but can accept.
Invalid: sign does not have change, symptom such as preceding.
Four, model case:
1, Lee, man, 40 years old.
Patient master states: the hemorrhoid recurrence.Existing 10 years of hemorrhoid outbreak once went to hospital to do once operation, after recurrence again, hemorrhage pain, but anus head Hui Na after an action of the bowels.Patient's body is thin partially, has a liking for tobacco and wine, and stool is slightly dry, and appetite is still good, and it is poor slightly to sleep, and yellow urine is few.The first visit complexion is slightly yellow, no fur in the middle of the thick fur Huang, tongue, rapid pulse.
Took Chinese medicine composition of the present invention 7, just soft, pain obviously alleviates during stool.Continue and obeyed Chinese medicine composition of the present invention 7, stopped bleeding during stool, painless, appetite increases, and sleep takes a turn for the better.The clothes Chinese medicine composition of the present invention that continues was consolidated 3, patient's recovery from illness.
2, the king so-and-so, woman, 45 years old.
Patient master states: hemorrhoid are shown effect surplus in the of ten year, and the time has hemorrhagely, and existing anus head after an action of the bowels exposes, swelling, and pain can not Hui Na, and stool is rare, and days three or four times, urine is normal, and appetite is still good, and it is slightly poor to sleep.Patient's body is slightly fat, the complexion general edema with yellowish tinge of the skin, and obvious edema, corpulent tongue is big, dark indentation, thick fur is white, and is slightly yellow, soft pulse.Now because of anus exposes, swelling, pain are sought medical advice.
Took Chinese medicine composition of the present invention 7, but anus head Hui Na after an action of the bowels, swelling, pain relief.Continue and obeyed Chinese medicine composition of the present invention 7, the hemorrhage disappearance of defecating, swelling is disappeared, and is painless, and sleep takes a turn for the better.Continue and obeyed Chinese medicine composition of the present invention 7, stool is normal, and rise once morning every day, soft stool, and edema disappears, patient's recovery from illness.
3, Wang, man, 42 years old.
The patient drove a taxi 7 years, have the defect of constipation, and stool is very dry, found just middle band blood last year, and during outbreak, blood stasis is deviate from, and is swollen like Fructus Vitis viniferae.Last lavatory more than 20 minute, cut-like pain, painful as directly to tremble, spasm, tic phenomenon often appear.Nowadays pain due to hemorrhoid so that difficulty on foot.
Took Chinese medicine composition of the present invention 7, stool deliquescing, pain relief.The clothes Chinese medicine composition of the present invention 7 days that continues, the free movement of the bowels frankness, just in depletion of blood, do not have just sensation not to the utmost, sit, upright, row all freely, the patient fully recovers entirely.
4, the king so-and-so, woman, 32 years old.
The patient before 10 years phenolics because of the firmly defecation of being hard and dry, there is a lump to deviate from the anus, toilet paper band blood phenomenon is arranged after an action of the bowels, never take notice of, stool often has lump to deviate from and bleeding after a period of time, oneself is bought ZHICHUANG GAO and smears, there is not obviously effect always, the state of an illness develops gradually and becomes heavy, and the lump of at every turn defecating is in this year all deviate from, and develops into a circle by one that begins and all deviate from, the hemorrhage situation of bleeding even spray blood being arranged that develops into by initial toilet paper band blood, more because of amount of bleeding, the symptom of existing anemia is examined.
Took Chinese medicine composition of the present invention 7, lump is deviate to alleviate, and the amount of having blood in stool reduces.Continue and obeyed Chinese medicine composition of the present invention 7, stool is happy, and lump is not seen, and nothing is had blood in stool.The clothes Chinese medicine composition of the present invention that continues was consolidated 15, and stool is normal, patient's recovery from illness.
5, Liu, woman, 27 years old.
The patient from last year phenolics the anal lump occurs and deviate from, and hemorrhage with stool, in time go to a doctor, the state of an illness constantly increases the weight of.Lump develops into a plurality of by one, nearly two weeks is defecated at every turn and spray mass formed by blood stasis shape all occurred, symptoms such as dizzy, weak occur.When examining, disease meeting yellow skin is white, and the deficiency of vital energy is unable, light red tongue, thready and weak pulse.
Took Chinese medicine composition of the present invention 3, stopped bleeding.Continue and obeyed Chinese medicine composition of the present invention 10, lump disappears, and normal diet and defecation are no hemorrhage.Continue and obeyed Chinese medicine composition of the present invention 1 month, stool is normal, patient's recovery from illness.Pay a return visit no abnormal after 1 year.
6, Lee, man, 46 years old.
Patient's constipation is defecated and was with blood 2 years for many years.Hemorrhage on a small quantity greatly after an action of the bowels, color is scarlet, is the drop shape, and the sensation podex has wart to deviate from.Be diagnosed as internal pile hematochezia through local examination in hospital, and with external hemorrhoid.Treatment was not still felt any better for 1 year, sent out when ending when having blood in stool still, can not thoroughly cure.When examining, disease meeting yellow skin is white, and health is more fat, dimly red tongue, yellow and thin fur, thready and hesitant pulse.The anus inspection, 4 of following 4 external hemorrhoids of locating as seen about Semen Glycines size of tooth trace.
Took Chinese medicine composition of the present invention 3, evident in efficacy, do not see in second day behind the medicine.Continue and obeyed Chinese medicine composition of the present invention 15, idol has stopped bleeding.Continue and obeyed Chinese medicine composition of the present invention 1 month, do not see again, stool is normal.Follow up a case by regular visits to and do not see recurrence in 5 years so far.
7, Zhao so-and-so, man, 38 years old.
Patient's proctalgia when each stool appears in no obvious inducement before half a year, stool has blood, and feels to have anus to have thing to prolapse out, and blood is drop and descends sometimes, eats after the maror more obvious.Proctalgia when defecating recently, after an action of the bowels constant pain unbearably, sit to crouch can not, go to a doctor.
Took Chinese medicine composition of the present invention 3, evident in efficacy, pain relief, the minimizing of having blood in stool.Continue and obeyed Chinese medicine composition of the present invention 20, the transference cure of having blood in stool, but stool is dried partially, and pain is arranged slightly.Continue and obeyed Chinese medicine composition of the present invention 1 month, stool is normal, and pain disappears, patient's recovery from illness.
8, Lee so-and-so, man, 25 years old.
The patient is because spicy eat many, bleeding is arranged during stool, do not do disposal, the state of an illness increases the weight of gradually, the interior circle lump of anus is deviate from when now defecating, all bleed, pain was obvious after the other day party was drunk, and can not be back to voluntarily in the anus at every turn, spray blood is more, do not do disposal, last pain comes to go to a doctor unbearably always.
Took Chinese medicine composition of the present invention 3, but anus head Hui Na after an action of the bowels, swelling, pain relief.Continue and obeyed Chinese medicine composition of the present invention 7, blood ends swollen disappearing, and painless, diet is normal.Continue and obeyed Chinese medicine composition of the present invention 35, the symptom complete obiteration, stool is normal, patient's recovery from illness.
Five, therapeutic outcome:
In the 75 routine cases of being accepted for medical treatment,, wherein cure 23 examples through treatment in 2 months, produce effects 32 examples, effective 20 examples, invalid 0 example, total effective rate reaches 100%.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to the treatment hemorrhoid patients.
Claims (7)
1. Chinese medicine composition for the treatment of hemorrhoid is characterized in that: mainly contain following bulk drugs and form:
1～100 part in Flos Sophorae, 1～150 part of the Fructus Sophorae, 1～100 part of the Flos Sophorae Immaturus, 1～150 part in Poria, 1～120 part of Radix Sophorae Flavescentis, 1～120 part of Radix Scrophulariae, 1～100 part of Rhizoma Atractylodis, 1～120 part of the Rhizoma Atractylodis Macrocephalae, 1～120 part of Rhizoma Dioscoreae, 1～100 part of Eupolyphaga Seu Steleophaga, 1～120 part of Fructus Toosendan, 1～50 part in catechu, 1～50 part of Pyritum, 1～100 part of Platycladi Cacumen carbonisatum, 1～120 part of Radix Sanguisorbae, 1～50 part of Spina Gleditsiae, 1～50 part of Squama Manis, 1～120 part of Flos Lonicerae, 1～100 part of Herba Violae, 1～120 part of Radix Arnebiae (Radix Lithospermi), 1～50 part of Herba Lobeliae Chinensis, 1～100 part of Herba Hedyotidis Diffusae, 1～100 part of water clock, 1～100 part of Rhizoma Smilacis Glabrae, 1～120 part of Cortex Lycii, 1～100 part of Radix Stellariae, 1～100 part of Rhizoma Picrorhizae, 1～120 part of Herba Taraxaci, 1～50 part of Fructus Forsythiae, 1～120 part of Radix Astragali, 1～120 part of the Radix Paeoniae Alba, 1～120 part of Radix Angelicae Sinensis, 1～50 part of Olibanum (processed), 1～50 part of Myrrha (processed), 1～150 part of Radix Trichosanthis, 1～50 part of Fructus Gardeniae, 1～120 part of Radix Scutellariae, 1～100 part of Rhizoma Coptidis, 1～120 part of favus skin.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
30 parts in Flos Sophorae, 50 parts of the Fructuss Sophorae, 30 parts of the Flos Sophorae Immaturus, 50 parts in Poria, 20 parts of Radix Sophorae Flavescentiss, 20 parts of Radix Scrophulariaes, 20 parts of Rhizoma Atractylodis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Rhizoma Dioscoreaes, 15 parts of Eupolyphaga Seu Steleophagas, 20 parts of Fructus Toosendans, 15 parts in catechu, 15 parts of Pyritums, 30 parts of Platycladi Cacumen carbonisatum, 30 parts of Radix Sanguisorbaes, 15 parts of Spina Gleditsiae, 15 parts of Squama Maniss, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 20 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes, 20 parts of water clocks, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 30 parts of Radix Astragali, 20 parts of the Radix Paeoniae Albas, 30 parts of Radix Angelicae Sinensis, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 30 parts of Radix Trichosanthis, 15 parts of Fructus Gardeniaes, 20 parts of Radix Scutellariaes, 15 parts of Rhizoma Coptidis, 30 parts of favus skins.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
1～120 part of Cortex Fraxini, 1～100 part of Radix Rehmanniae, 1～100 part of Radix Paeoniae Rubra, 1～50 part of Rhizoma Paridis, 1～50 part of Indigo Naturalis, 1～100 part of Herba Patriniae, 1～50 part of Aspongopus, 1～100 part of Rhizoma Chuanxiong, 1～50 part of Lignum Aquilariae Resinatum, 1～100 part of Lignum Dalbergiae Odoriferae, 1～100 part of Aloe, 1～100 part of Radix Salviae Miltiorrhizae, 1～100 part of Radix Codonopsis, 1～120 part of Cortex Moutan, 1～100 part of Semen Pruni, 1～100 part of Radix Et Rhizoma Rhei, 1～100 part of Lignum Sappan, 1～30 part of Sanguis Draxonis, 1～100 part of Semen Euryales, 1～50 part in Semen Nelumbinis, 1～50 part of Halloysitum Rubrum, 1～100 part of Gypsum Fibrosum, 1～50 part of the Rhizoma Anemarrhenae, 1～50 part of Limonitum, 1～50 part of Pericarpium Granati.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
30 parts of Cortex Fraxinis, 20 parts of Radix Rehmanniae, 20 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Paridis, 15 parts of Indigo Naturaliss, 30 parts of Herba Patriniae, 15 parts of Aspongopuss, 15 parts of Rhizoma Chuanxiongs, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Lignum Dalbergiae Odoriferaes, 20 parts of Aloes, 20 parts of Radix Salviae Miltiorrhizaes, 30 parts of Radix Codonopsis, 20 parts of Cortex Moutans, 20 parts of Semen Prunis, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Lignum Sappans, 10 parts of Sanguis Draxonis, 20 parts of Semen Euryaless, 15 parts in Semen Nelumbinis, 15 parts of Halloysitum Rubrums, 20 parts of Gypsum Fibrosum, 15 parts of the Rhizoma Anemarrhenaes, 25 parts of Limonitum, 25 parts of Pericarpium Granatis.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1～6 in preparation antihaemorrhoidals thing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010189679A CN101816742A (en) | 2010-06-02 | 2010-06-02 | Chinese medicinal composition for treating hemorrhoids and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010189679A CN101816742A (en) | 2010-06-02 | 2010-06-02 | Chinese medicinal composition for treating hemorrhoids and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101816742A true CN101816742A (en) | 2010-09-01 |
Family
ID=42652119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010189679A Pending CN101816742A (en) | 2010-06-02 | 2010-06-02 | Chinese medicinal composition for treating hemorrhoids and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101816742A (en) |
Cited By (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101991695A (en) * | 2010-10-29 | 2011-03-30 | 韩世昌 | Traditional Chinese medicine pill for treating hemorrhoids and preparation method thereof |
| CN102000196A (en) * | 2010-11-23 | 2011-04-06 | 王清令 | Chinese medicine composition for treating anal fistula |
| CN102225099A (en) * | 2011-06-07 | 2011-10-26 | 张惠芳 | Chinese medicinal composition orally and externally used for treating hemorrhoid |
| CN102225101A (en) * | 2011-06-23 | 2011-10-26 | 李启雷 | Traditional Chinese medicine for treating hemorrhoids |
| CN102512614A (en) * | 2011-12-22 | 2012-06-27 | 黄廷芬 | Bath lotion for treating inflammatory external hemorrhoid |
| CN102526247A (en) * | 2012-01-13 | 2012-07-04 | 袁中伟 | Chinese medicine sitting bathing preparation for treating hemorrhoids sore |
| CN102526560A (en) * | 2010-12-23 | 2012-07-04 | 毛利进 | Medicine composition for treating hemorrhoids and preparation method thereof |
| CN102670699A (en) * | 2012-06-02 | 2012-09-19 | 吴帮友 | Traditional Chinese medicine for curing internal hemorrhoid |
| CN102872188A (en) * | 2012-09-29 | 2013-01-16 | 刘静 | Orally-taken medicine for treating haemorrhoids and preparation method thereof |
| CN102885955A (en) * | 2012-10-16 | 2013-01-23 | 何相飞 | Medicament for treating pulmonary actinomycosis infection after kidney transplantation operation |
| CN102988915A (en) * | 2011-09-18 | 2013-03-27 | 罗明雷 | Hip bath lotion for treating haemorrhoid |
| CN103251855A (en) * | 2013-05-27 | 2013-08-21 | 刘爱香 | Traditional Chinese medicine composition for treating damp-heat-downward-flow type haemorrhoids |
| CN103463449A (en) * | 2013-10-11 | 2013-12-25 | 雷会勇 | Traditional Chinese medicine composite used for treating haemorrhoids and preparation method and application thereof |
| CN103479931A (en) * | 2013-09-27 | 2014-01-01 | 刘建忠 | Medicine for treating haemorrhoids and preparation method thereof |
| CN103550090A (en) * | 2013-10-18 | 2014-02-05 | 桂林雪芙莲日化有限公司 | Traditional Chinese medicine toilet soap for preventing and treating haemorrhoids |
| CN103690702A (en) * | 2013-12-30 | 2014-04-02 | 孙亚平 | Traditional Chinese medicinal composition for treating dampness-heat-type hemorrhoids |
| CN103830506A (en) * | 2014-01-24 | 2014-06-04 | 河南科技大学第一附属医院 | Composite ointment used for rapid wound heal and preparation method thereof |
| CN103893669A (en) * | 2014-04-24 | 2014-07-02 | 赵永君 | Traditional Chinese medicine composition for treating tinea pedis as well as preparation method and application thereof |
| CN104257867A (en) * | 2014-09-24 | 2015-01-07 | 杜军伟 | Traditional Chinese medicine formula for treating hemorrhoids |
| CN104274598A (en) * | 2014-10-28 | 2015-01-14 | 合肥丰瑞隆生物科技有限公司 | Traditional Chinese medicine for treating haemorrhoids |
| CN104398729A (en) * | 2014-11-14 | 2015-03-11 | 济南新起点医药科技有限公司 | Traditional Chinese medicine composition treating blood stasis type hemorrhoid |
| CN104825826A (en) * | 2015-05-29 | 2015-08-12 | 佘延英 | Traditional Chinese medicine composition for treating hemorrhoids |
| CN105055600A (en) * | 2015-08-07 | 2015-11-18 | 成都市飞龙水处理技术研究所 | Decoction for effective treatment of rectal prolapse and preparation method thereof |
| CN105326996A (en) * | 2015-12-05 | 2016-02-17 | 徐萍 | Drug for treating hemorrhoids and preparation method thereof |
| CN105495213A (en) * | 2015-12-19 | 2016-04-20 | 覃敢 | Beverage for preventing and treating haemorrhoids and preparation method thereof |
| CN105998880A (en) * | 2016-08-05 | 2016-10-12 | 王瑞俭 | Oral medicine for treating hemorrhoids, and preparation method thereof |
| CN107625929A (en) * | 2017-09-26 | 2018-01-26 | 杨军训 | Change hemorrhoid external application cream, its preparation method and Chinese prescription hemorrhoid patch |
| CN108272983A (en) * | 2018-04-12 | 2018-07-13 | 刘晓武 | A kind of mixture and preparation method thereof of having blood in stool for treating Internal hemorrhoid hemorrhage |
-
2010
- 2010-06-02 CN CN201010189679A patent/CN101816742A/en active Pending
Cited By (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101991695A (en) * | 2010-10-29 | 2011-03-30 | 韩世昌 | Traditional Chinese medicine pill for treating hemorrhoids and preparation method thereof |
| CN102000196B (en) * | 2010-11-23 | 2012-01-18 | 王清令 | Chinese medicine composition for treating anal fistula |
| CN102000196A (en) * | 2010-11-23 | 2011-04-06 | 王清令 | Chinese medicine composition for treating anal fistula |
| CN102526560A (en) * | 2010-12-23 | 2012-07-04 | 毛利进 | Medicine composition for treating hemorrhoids and preparation method thereof |
| CN102526560B (en) * | 2010-12-23 | 2013-12-04 | 毛利进 | Medicine composition for treating hemorrhoids and preparation method thereof |
| CN102225099A (en) * | 2011-06-07 | 2011-10-26 | 张惠芳 | Chinese medicinal composition orally and externally used for treating hemorrhoid |
| CN102225101A (en) * | 2011-06-23 | 2011-10-26 | 李启雷 | Traditional Chinese medicine for treating hemorrhoids |
| CN102225101B (en) * | 2011-06-23 | 2012-11-21 | 李启雷 | Traditional Chinese medicine for treating hemorrhoids |
| CN102988915A (en) * | 2011-09-18 | 2013-03-27 | 罗明雷 | Hip bath lotion for treating haemorrhoid |
| CN102512614A (en) * | 2011-12-22 | 2012-06-27 | 黄廷芬 | Bath lotion for treating inflammatory external hemorrhoid |
| CN102526247A (en) * | 2012-01-13 | 2012-07-04 | 袁中伟 | Chinese medicine sitting bathing preparation for treating hemorrhoids sore |
| CN102526247B (en) * | 2012-01-13 | 2013-07-17 | 袁中伟 | Chinese medicine sitting bathing preparation for treating hemorrhoids sore |
| CN102670699A (en) * | 2012-06-02 | 2012-09-19 | 吴帮友 | Traditional Chinese medicine for curing internal hemorrhoid |
| CN102872188A (en) * | 2012-09-29 | 2013-01-16 | 刘静 | Orally-taken medicine for treating haemorrhoids and preparation method thereof |
| CN102872188B (en) * | 2012-09-29 | 2015-01-28 | 刘静 | Orally-taken medicine for treating haemorrhoids and preparation method thereof |
| CN102885955A (en) * | 2012-10-16 | 2013-01-23 | 何相飞 | Medicament for treating pulmonary actinomycosis infection after kidney transplantation operation |
| CN103251855A (en) * | 2013-05-27 | 2013-08-21 | 刘爱香 | Traditional Chinese medicine composition for treating damp-heat-downward-flow type haemorrhoids |
| CN103251855B (en) * | 2013-05-27 | 2014-11-12 | 刘爱香 | Traditional Chinese medicine composition for treating damp-heat-downward-flow type haemorrhoids |
| CN103479931A (en) * | 2013-09-27 | 2014-01-01 | 刘建忠 | Medicine for treating haemorrhoids and preparation method thereof |
| CN103479931B (en) * | 2013-09-27 | 2015-11-11 | 刘建忠 | A kind of medicine for the treatment of hemorrhoid and preparation method thereof |
| CN103463449A (en) * | 2013-10-11 | 2013-12-25 | 雷会勇 | Traditional Chinese medicine composite used for treating haemorrhoids and preparation method and application thereof |
| CN103550090A (en) * | 2013-10-18 | 2014-02-05 | 桂林雪芙莲日化有限公司 | Traditional Chinese medicine toilet soap for preventing and treating haemorrhoids |
| CN103690702A (en) * | 2013-12-30 | 2014-04-02 | 孙亚平 | Traditional Chinese medicinal composition for treating dampness-heat-type hemorrhoids |
| CN103830506A (en) * | 2014-01-24 | 2014-06-04 | 河南科技大学第一附属医院 | Composite ointment used for rapid wound heal and preparation method thereof |
| CN103830506B (en) * | 2014-01-24 | 2016-05-04 | 河南科技大学第一附属医院 | A kind of compound ointment for wound healing and preparation method thereof |
| CN103893669A (en) * | 2014-04-24 | 2014-07-02 | 赵永君 | Traditional Chinese medicine composition for treating tinea pedis as well as preparation method and application thereof |
| CN103893669B (en) * | 2014-04-24 | 2016-05-11 | 赵永君 | A kind of Chinese medicine composition for the treatment of tinea pedis and preparation method thereof and application |
| CN104257867A (en) * | 2014-09-24 | 2015-01-07 | 杜军伟 | Traditional Chinese medicine formula for treating hemorrhoids |
| CN104274598A (en) * | 2014-10-28 | 2015-01-14 | 合肥丰瑞隆生物科技有限公司 | Traditional Chinese medicine for treating haemorrhoids |
| CN104398729A (en) * | 2014-11-14 | 2015-03-11 | 济南新起点医药科技有限公司 | Traditional Chinese medicine composition treating blood stasis type hemorrhoid |
| CN104825826A (en) * | 2015-05-29 | 2015-08-12 | 佘延英 | Traditional Chinese medicine composition for treating hemorrhoids |
| CN105055600A (en) * | 2015-08-07 | 2015-11-18 | 成都市飞龙水处理技术研究所 | Decoction for effective treatment of rectal prolapse and preparation method thereof |
| CN105326996A (en) * | 2015-12-05 | 2016-02-17 | 徐萍 | Drug for treating hemorrhoids and preparation method thereof |
| CN105495213A (en) * | 2015-12-19 | 2016-04-20 | 覃敢 | Beverage for preventing and treating haemorrhoids and preparation method thereof |
| CN105998880A (en) * | 2016-08-05 | 2016-10-12 | 王瑞俭 | Oral medicine for treating hemorrhoids, and preparation method thereof |
| CN107625929A (en) * | 2017-09-26 | 2018-01-26 | 杨军训 | Change hemorrhoid external application cream, its preparation method and Chinese prescription hemorrhoid patch |
| CN108272983A (en) * | 2018-04-12 | 2018-07-13 | 刘晓武 | A kind of mixture and preparation method thereof of having blood in stool for treating Internal hemorrhoid hemorrhage |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101816742A (en) | Chinese medicinal composition for treating hemorrhoids and preparation method thereof | |
| CN101869691B (en) | Chinese medicinal composition for treating dysmenorrhea and preparation method thereof | |
| CN101961464B (en) | Chinese medicinal composition for treating jaundice and preparation method thereof | |
| CN100460008C (en) | Chinese medicine composition for treating cancer | |
| CN101785845B (en) | Traditional Chinese medicine combination and preparation method for intestinal flatulence treatment | |
| CN101757569A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and cerebral infarction and preparation method thereof | |
| CN102423366B (en) | Chinese medicinal composition for treating metrorrhagia and metrostaxis | |
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN101972457B (en) | Chinese medicinal composition for treating edema during menstruation and preparation method thereof | |
| CN101757566A (en) | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof | |
| CN101966322A (en) | Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof | |
| CN101766789B (en) | Chinese medicine composite for treating appendicitis and preparation method thereof | |
| CN102228603B (en) | Chinese medicine for treating retention of urine | |
| CN101961479A (en) | Chinese medicinal composition for treating bellyache and preparation method thereof | |
| CN101773634A (en) | Chinese medicine composition for treating abdominal distention and fullness and preparation method thereof | |
| CN101972432B (en) | Chinese medicinal composition for treating diarrhea associated with menstruation and preparation method thereof | |
| CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
| CN101961480A (en) | Traditional Chinese medicinal composition for treating hematochezia and preparation method thereof | |
| CN101966321A (en) | Traditional Chinese medicinal composition for treating breast cancer and preparation method thereof | |
| CN101797352A (en) | Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof | |
| CN101837112B (en) | Chinese medicinal composition for curing irregular menstrual period and preparation method thereof | |
| CN102727779B (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
| CN101837113A (en) | Chinese medicinal composition for curing fever during menstruation and preparation method thereof | |
| CN101810823B (en) | Chinese medicinal composition for treating renal cyst diseases and use of preparing medicine | |
| CN101966289A (en) | Chinese medicinal composition for treating frigidity and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20100901 |
|
| C12 | Rejection of a patent application after its publication |